Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2022
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy aloneScott D Berkowitz, Rupert M Bauersachs, Michael Szarek, et al.JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.Journal of the American College of Cardiology|October 29, 2021
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Manesh R Patel, Rupert M Bauersachs, et al.European Heart Journal|August 25, 2021
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trialMori J Krantz, Sebastian E Debus, Judith Hsia, et al.Circulation|October 12, 2021
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PADConnie N Hess, E Sebastian Debus, Mark R Nehler, et al.The New England Journal of Medicine|March 30, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationMarc P Bonaca, Rupert M Bauersachs, Sonia S Anand, et al.Journal of Vascular Surgery|December 5, 2022
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduitsNicholas Govsyeyev, Mark Nehler, Michael S Conte, et al.Circulation|August 12, 2021
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD TrialE Sebastian Debus, Mark R Nehler, Nicholas Govsyeyev, et al.Vascular Medicine (London, England)|March 17, 2024
Methods, design, and initial results of an angiographic core lab from VOYAGER-PADR Kevin Rogers, Joerg Herold, Nicholas Govsyeyev, et al.Pageof 2